Elin has a degree in Chemical Engineering (2011) and a PhD in Pharmaceutical Sciences (2016), both from Uppsala University, Sweden. The focus of her research is pharmacokinetic and pharmacodynamic population modeling of anti-tuberculosis drugs. Currently Elin holds researcher positions at Radboud University Medical Center, Nijmegen, Netherlands, and at Uppsala University. Elin is active within the PanACEA consortium and the pediatric clinical trials networks IMPAACT and is part of the WHO Task Force on PK/PD of tuberculosis medicines
